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Abstract
Upon injury to the vessel wall, interactions between platelets and the subendothelial collagen
play a critical role in initiating the clotting cascade. The modulation of platelet-collagen adhesion
by  non-platelet  derived  receptors  present  in  the  peripheral  blood  is  not  well-understood.
Discoidin domain receptors (DDRs) are a unique family of collagen-binding receptors that are
activated by their ligand collagen, and play an important role in collagen remodeling. This study
aims to determine expression of DDRs in leukocyte and in platelets in the human peripheral
blood with the long term goal of identifying the role of DDRs in modulating platelet-collagen
interactions. 
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Introduction
Platelet-collagen interactions play crucial roles in clinically relevant scenarios such as stroke,
atherosclerosis, and myocardial infarction. Arterial thrombosis, a leading cause of myocardial
infarction, is initiated when intimal collagen is exposed to the flowing peripheral blood. Platelets
begin  the  coagulation  cascade  when  they adhere  to  collagen  via  the  GPVI  receptor  and  to
collagen bound vWF via the GP1b receptor present on the platelet surface. Besides GPVI and
GP1b,  the integrins  21 present  on the platelet  surface are  also known to mediate  platelet-
collagen  interactions.  In  recent  years  several  new  collagen  receptors  have  been  identified.
However, their expression in peripheral blood cell-types has not been well-characterized. This is
especially  important  as  non-platelet  derived  collagen  receptors  may  also  play  a  role  in
modulating platelet-collagen interactions.
Receptor tyrosine kinases (RTKs) are transmembrane receptors which play crucial roles in cell-
signaling1. The discoidin domain receptors DDR1 and DDR2 are a family of RTKs which consist
of an extracellular domain (ECD), transmembrane domain, and intracellular kinase domain1,  6
(Figure 1). DDR1 and DDR2 are differentiated from other RTKs in that their ECDs bind to and
are activated by triple helical collagens1.  Interactions between DDRs and collagen have been
shown to  play  roles  in  the  migration,  proliferation,  differentiation,  and  survival  of  multiple
mammalian cell types 1, 2, 3, . Dysregulation of the DDRs are implicated in the 
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pathogenisis  of  multiple  disease  states,  including
atherosclerosis2,  3,  cancer4,  5,  and  myocardial
infarction1, 5. 
The current study aims to evaluate the expression of
DDR1 and DDR2 in human peripheral blood via the
following specific aims. 
Specific Aim: Determine expression of DDR1 and DDR2 in leukocytes and platelets. mRNA
from human platelets and leukocytes was used to analyze for DDR expression using PCR based
approach. 
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Figure 1: DDR structure. The 
exctracellular discoidin domain is 
activated when bound to collagen, 
leading to autophosphorylation of 
intracellular tyrosine residues6.
Methods
Blood Collection and Platelet Preparation
8 mL of whole blood from available healthy donors was drawn into either sodium citrate or
EDTA containing tubes via our approved IRB protocol. Blood samples  were centrifuged at 200
x g for 15 minutes, resulting in a translucent layer containing platelet-rich-plasma (PRP), a buffy
coat (BC) containing leukocytes, and an opaque red layer containing red blood cells (RBC).  The
PRP layer was seperated from the BC layer using wide bore pipette tips and the RBC layer was
discarded. PRP and BC were centrifuged at 5000 x g for 5 minutes to yield solid cell pellets
consisting primarily of platelet or leukocytes respectively. The cell pellets were rinsed with room
temperature PBS, and centifuged again at 5000 x g for 5 minutes to regain the cell pellet.  Cells
were lysed in 250 uL of TRIzol Reagent (Invitrogen, Carlsbad, CA, USA) and stored at -20 oC.
mRNA Precipitation
mRNA precipitation followed a modified version of the manufacturer’s protocol included with
the  TRIzol Reagent. Cell homogenates were incubated for 5 minutes at room temperature to
allow nucleoprotein complexes to dissociate. 50 uL of choloroform was added, and homogenates
were vortexed and incubated another 2 minutes at room temperature. The samples were then
centrifuged at 12000 x g for 15 minutes at 4 oC,  separating the mixture into a lower red phase
and,  and  a  colorless  upper  phase  containing  mRNA.   The  colorless  phase  was  carefully
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transferred to a new tube, while the rest was discarded. The mRNA was precipitated by adding at
least 125 uL  of isopropyl, freezing the mixture at -80 oC for at least an hour, and centrifuging at
12000 xg for 10 minutes at 4 oC.  The mRNA precipitate formed as a nearly invisible pellet on
the bottom of the tube. After removing the supernatant, the mRNA pellet was washed twice by
adding  0.5  mL of  75%  ethanol,  vortexing  to  break  up  the  pellet,  and  re-precipitation  by
centrifuging at 7500 x g for 5 minutes at 4 oC.  The ethanol was removed from the tube, and the
mRNA was allowed to air dry for about ten minutes, or until the mRNA pellet was translucent.
We dissolved the mRNA in 20 uL of RNase-free water by repeatedly passing the pellet through a
pipette tip and incubating for 10 minutes at 60 oC. The 260/280 ratio of the mRNA was measured
using a Beckman Coulter 730 Spectrophotometer (Beckman Coulter, Inc., Pasadena, CA, USA).
Only samples with a 260/280 ratio above 1.6 were used. mRNA purity was also assessed by
running PCR using DDR1 primers (Table 1), which shows an additional 359 bp band due to
genomic DNA contamination (Figure 2). The mRNA samples were stored at -20 oC.  
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Figure 2 : Representative gel showing detection of DNA 
contamination. Bands at 359 bp are PCR products of DNA, 
while lighter bands at 100 bp are the correct mRNA products.
359 bp
100 bp
First-Strand cDNA Synthesis
cDNA synthesis from isolated mRNA followed the protocol included with SuperScript II RT
(Invitrogen). 500 ng of isolated mRNA was mixed with 1 uL Oligo(dT) (Invitrogen) , 1 uL dNTP
Mix (Initrogen), and RNase-free water to a final reaction volume of 12 uL. The mixture was
heated to 65 oC for 5 minutes and chilled on ice. Thereafter 4 uL First-Strand Buffer (Invitrogen)
and 2 uL 0.1M DTT (Invitrogen) were added, mixed by gently passing through pipette tip,  and
incubated at 42 oC for 2 minutes. 1 uL of SuperScript II RT (Invitrogen) and Rnase-free water
were added to a final volume of 20 uL, and the mixture was allowed to sit at room temperature
for 10 minutes. The reaction was completed by incubation at 42  oC for 50 min, followed by
incubation at 70 oC for 15 minutes. cDNA samples were stored at -20 oC.
PCR
PCR reactions were prepared using 25-100 ng first-strand cDNA, 5 uL PCR Buffer in MgCl2+
(Hoffman-La Roche, Basel, Switzerland) , 1 uL dNTP Mix, 5 uL forward primer, 5 uL reverse
primer, and 0.4 uL Taq DNA Polymerase (Hoffan-La Roche). The mixtures were heated to 95 oC
for 4 minutes, then went through 40 cycles of denaturation at 95 oC for 1 minute, annealing at
primer-specific annealing temperatures (Table 1) for 1 minute, elongation at 72 oC for 2 minutes,
and a final elongation at 72 oC for 7 minutes. PCR products were stored at -20 oC.
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Gel Electrophoresis
PCR products  were separated  based on molecular  weight  using  standard  gel  electrophoresis
protocols. PCR products were loaded into 1.5% agarose gels, allowed to run for 45 minutes at
100 V, and imaged in UV light. 
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Table 1: List of primer sequences, molecular weights of mRNA PCR products, and primer 
melting temperatures. DDR primers taken from Ruiz et al.7, GP1ba and HLADQb primers taken 
from Paul et al.8
DDR1 DDR2 GP1ba HLADQb
Forward Primer
Reverse Primer (reverse complement)
mRNA MW (bp) 100 68 282 300
Melting Temp ( Degrees Celsius) 69(F) 66.5(R) 68.8(F) 67.6(R) 73.7(F) 77.8(R) 58.3(F) 65.6(R)
GCG TCT GTC TGC GGG 
TAG AG
TGT TCC TGC TGC 
TGC CTA TCT T
GGT GCG TGC CAC 
AAG GAC TGT
GTC TCA ATT ATG 
TCT TGG AA 
AGA CAA TGT ATT TAT 
CTG AGG CCG T
ATC CAG CTA TAT 
GCC GCT ATC CT
CGT CCC GGA GCC 
CGC CCC AAA
AGC AAG ATG CTG 
AGT GGC
Results
Peripheral blood samples obtained from n=3 healthy subjects was utilized to obtain mRNA from
the leukocyte fraction and the platelet fraction. Two platelet mRNA samples (PL1: from top 1 ml
of PRP) and PL2: second 1 ml of PRP) and one leukocyte mRNA sample (WBC) were isolated
from fractions, and converted to cDNA. All three samples demonstrated 260/280 ratios above
1.6, and tested negative for DNA contamination using PCR as described in the methods section.
PCR was run using 100ng template cDNA from all three samples.
Figure 3 shows results obtained using PCR. .  The WBC sample tested positive for HLA-DQb, a
leukocyte specific gene while PL1 and PL2 both tested negative.  All three samples displayed the
bands corresponding to GP1ba, a platelet specific marker. This was expected, as our buffy coat
layer contains both platelets and leukocytes, while the PL samples contain only platelets. 
We then tested for expression of DDR1 and DDR2 in leukocyte and platelet samples. Plasmids
containing DDR1 (DDR1-P) and DDR2 (DDR2-P) were  used as  both  positive  and negative
controls. WBC samples showed bands for both DDR1 and DDR2.  However neither PL1 or PL2
displayed bands for DDR1 or DDR2.  
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8Figure 3 : PCR products from mRNA samples WBC, PL1, and PL2 as well as control plasmids 
DDR1-P and DDR2-P  were loaded into 1.5% agarose gels and run at 100 V for 45 minutes.  
Leukocyte expression of DDR1 and DDR2  was demonstrated, while platelets did not express 
either DDR.
Discussion and Conclusion
DDR1  and  DDR2  are  expressed  in  leukocytes.  These  results  confirm  earlier  Western  Blot
analysis  performed in our lab,  as well  as in  the literature9.  While the bands in Figure 3 are
relatively weak, we believe they are prominent enough to confirm expression, and future work
aim at strengthening the bands by optimizing the PCR reaction. Expression of DDR1 and DDR2
in leukocytes support previous studies indicating DDR mediates leukocyte-collagen interactions
during inflammation2.
Platelets do not express DDR1 or DDR2. Relatively little research has focused on expression of
DDR1 and DDR2 in peripheral blood. A study by Abonnante et al.10 used Western Blot analysis
to show that platelets  express DDR1, which disagrees with our results.  In this  earlier  study,
leukocyte contamination of platelet samples and/or non-specific binding of DDR1 antibody has
not  been  well-characterized.  Our  use  of  both  positive  and  negative  plasmid  controls  in
determining DDR1 and DDR2 expression in platelets creates a more stringent analyis, indicating
that platelets do not express either DDR. 
Overexposing the gel revealed very faint bands for PL1 using both HLA-DQb and DDR1. The
HLA-DQb band indicates possible leukocyte contamination, which could in turn be responsible
for the DDR1 band. Future studies should seek to ensure complete purity of platelet samples,
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possibly by utilizing methods described by Paul et al.8 
Understanding the expression of discoidin domain receptors  in  different  blood fractions  will
allow us to further understand platelet-collagen interactions in the whole blood. 
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